| Efficacy on pain | Efficacy on fever | Global efficacy (n = 31) | ||
---|---|---|---|---|---|
NS (n = 8) | Algoplus (n = 7 or 8) | Global (n = 16) | (n = 15) | Pain and fever combined | |
Primary Outcomes- % [CI] | |||||
 At 60 min | 62.5 | 87.5 | 75 [47.62-92.73] | 66.67 [38.38-88.17] | 70.97 [51.96-85.78] |
Secondary outcomes- Number (%) [CI] | |||||
 At 30 min | 25 | 14.29 | 20 [4.33-48.09] | 26.67 [7.79-55.6] | 23.33 [9.93-42.28] |
 At 180 min | 75 | 100 | 87.5 [61.65-98.45] | 86.67 [59.54-98.63] | 87.10 [70.17-96.37] |